Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.
View original article
Contributor: Rebecca Robbins and Gina Kolata
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.
View original article
Contributor: Rebecca Robbins and Gina Kolata